ClinicalTrials.govpublic full text
Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
neoplasms, uterine cervix, metastatic cervical cancer, pazopanib, erb1/erb2, lapatinib, persistent, vegf, recurrent, advanced, figo stage ivb, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 812684
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.